Limitations
NAFLD, PWH, hepatic steatosis, fibrosis
DISEASE, HEPATIC STEATOSIS, FIBROSIS
We used non-invasive assessment methods for hepatic steatosis and fibrosis, whilst the gold standard, liver biopsy, would have permitted more accurate classification of disease. However, recruiting a sufficient sample of PWH and mild NAFLD to a randomised study requiring consecutive liver biopsies presents feasibility challenges. We did not control for all ART classes, and emerging data have highlighted the possible association of INSTI and TAF with NAFLD progression, as well as a possible protective role for tenofovir disoproxil, although data are conflicting [